Outlook and Opportunities: Healthcare In the Era Of Personalized Medicine

30 September 2009 Past Event

Personalized medicine and cellular therapeutics could open new doors to safe and effective therapies. Research institutions, pharmaceutical companies and investors are looking to new avenues in which to advance the discovery of medicine tailored to fit the individual patient. On the renewed vitality of the stem cell are the hopes of millions of patients coping with diseases that may now become treatable. Dr. Ralph Garippa, Research Leader at Roche, Department of Discovery Technologies, will address the potential impact of cellular therapeutics on diagnostic medicine and personalized therapeutics within the pharmaceutical industry. He will address the impact these technologies may have both in the U.S. and abroad with respect to R&D and viable opportunities that may exist for life science companies and investors alike.

Insights

What’s Next for Blockchain and Crypto?
01 December 2022
Innovative Technology Insights
Case Law Update: Disputes Relating to Supply Chain Disruptions Hit the Courts
01 December 2022
Manufacturing Industry Advisor
Foley Partner André Thiollier Moderates Global Venture Market Session at BayBrazil Conference
01 December 2022
Foley Ignite
Podcast Episode 96: Eric Williams, Associate
01 December 2022
Foley Career Perspectives
What You Should Know About Payor/Provider Convergence
25-26 January 2023
Los Angeles, CA
ATA EDGE2022 Policy Conference | American Telemedicine Association
7-9 December 2022
Washington, D.C.
CLE Weeks
5-16 December 2022
Milwaukee, WI
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region